DCT

3:19-cv-01374

Amgen Inc v. Tanvex Biopharma USA Inc

General
Filed
07/23/19
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Judge
Period
PO Win Rate
--
42%